Skip to main content

OraSure Technologies Sets 2008 Annual Meeting Date

OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that its 2008 Annual Meeting of Stockholders is scheduled to be held on Tuesday, May 13, 2008, at the Historic Hotel Bethlehem, Bethlehem, Pennsylvania. Stockholder proposals must be received no later than December 10, 2007, in order to be considered for inclusion in the Companys Proxy Statement under relevant Securities and Exchange Commission rules and no later than February 13, 2008, in order to be considered at the Annual Meeting or to nominate a Director under OraSure Technologies Bylaws.

About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians offices, and commercial and industrial entities.

OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pa., the company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. For more information on the Company, please go to www.orasure.com.

Contacts:

OraSure Technologies, Inc.
Ronald H. Spair
Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.